Apogee Therapeutics, Inc. (APGE) Ownership

$38.37

$1.23 (3.31%)
Last update: 04:00 PM EST
Day's range
$37.4
Day's range
$39.03

Apogee Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
OCTAGON CAPITAL ADVISORS LP 05/15/2025 10.70 M $14.87 M   100.00% 18.39%
VR ADVISER, LLC 05/15/2025 8.49 M $317.31 M   0.00% 14.59%
FMR LLC 05/12/2025 7.49 M $279.96 M   -0.08% 12.88%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 5.49 M $204.95 M   21.44% 9.43%
BLACKROCK, INC. 05/02/2025 2.91 M $108.75 M   -4.41% 5.00%
RTW INVESTMENTS, LP 05/15/2025 2.71 M $101.32 M   0.00% 4.66%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2025 2.34 M $87.41 M   -10.20% 4.02%
VANGUARD GROUP INC 05/09/2025 2.08 M $77.81 M   -0.71% 3.58%
JANUS HENDERSON GROUP PLC 05/15/2025 1.79 M $71.29 M   58.03% 3.08%
MERCER GLOBAL ADVISORS INC /ADV 05/15/2025 1.64 M $61.28 M   127.77% 2.82%
RA CAPITAL MANAGEMENT, L.P. 05/15/2025 1.57 M $58.64 M   0.00% 2.70%
BRAIDWELL LP 05/15/2025 1.54 M $57.55 M   0.00% 2.65%
STATE STREET CORP 05/15/2025 1.31 M $49.08 M   -10.45% 2.26%
ALLIANCEBERNSTEIN L.P. 05/15/2025 1.28 M $47.86 M   -5.48% 2.20%
AFFINITY ASSET ADVISORS, LLC 05/14/2025 1.15 M $43.01 M   23.56% 1.98%
PERCEPTIVE ADVISORS LLC 05/15/2025 1.12 M $41.95 M   7.21% 1.93%
WOODLINE PARTNERS LP 05/15/2025 1.06 M $39.64 M   4.47% 1.82%
JPMORGAN CHASE & CO 05/12/2025 962.63 K $35.96 M   2,483.90% 1.65%
PARADIGM BIOCAPITAL ADVISORS LP 05/15/2025 961.71 K $35.93 M   -25.09% 1.65%
FRANKLIN RESOURCES INC 05/13/2025 876.08 K $32.73 M   1.14% 1.51%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 835.70 K $31.23 M   2.40% 1.44%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 821.85 K $30.71 M   -21.92% 1.41%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 727.00 K $27.16 M   202.66% 1.25%
UBS GROUP AG 05/13/2025 701.91 K $26.22 M   29.67% 1.21%
SIREN, L.L.C. 05/23/2025 594.99 K $22.23 M   -20.38% 1.02%
POLAR CAPITAL HOLDINGS PLC 05/15/2025 550.00 K $20.55 M   100.00% 0.95%
MORGAN STANLEY 05/15/2025 519.94 K $19.42 M   148.14% 0.89%
BARCLAYS PLC 05/15/2025 498.63 K $18.63 M   4.59% 0.86%
BANK OF AMERICA CORP /DE/ 05/15/2025 425.88 K $15.91 M   303.52% 0.73%
JEFFERIES FINANCIAL GROUP INC. 05/08/2025 421.80 K $15.76 M   -52.47% 0.72%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 392.49 K $14.66 M   29.65% 0.67%
NORTHERN TRUST CORP 05/13/2025 314.48 K $11.75 M   -3.92% 0.54%
JENNISON ASSOCIATES LLC 05/05/2025 293.76 K $10.97 M   -5.97% 0.50%
GOLDMAN SACHS GROUP INC 06/27/2025 290.70 K $10.86 M   -28.75% 0.50%
COMMODORE CAPITAL LP 05/15/2025 290.00 K $10.83 M   0.00% 0.50%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 271.88 K $10.16 M   -2.02% 0.47%
MILLENNIUM MANAGEMENT LLC 05/15/2025 260.34 K $9.73 M   99.99% 0.45%
TWO SIGMA INVESTMENTS, LP 05/15/2025 252.14 K $9.42 M   -5.38% 0.43%
VICTORY CAPITAL MANAGEMENT INC 05/02/2025 232.98 K $8.70 M   4.45% 0.40%
FIRST TURN MANAGEMENT, LLC 05/15/2025 229.68 K $8.58 M   -9.12% 0.39%
BANK OF NEW YORK MELLON CORP 04/29/2025 214.23 K $8.00 M   93.30% 0.37%
TANG CAPITAL MANAGEMENT LLC 05/15/2025 200.00 K $7.47 M   100.00% 0.34%
CAPITAL WORLD INVESTORS 05/12/2025 193.90 K $7.24 M   -5.46% 0.33%
BLACKSTONE INC. 05/15/2025 183.75 K $6.86 M   129.68% 0.32%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 05/15/2025 167.99 K $6.28 M   308.68% 0.29%
CAPTION MANAGEMENT, LLC 05/15/2025 151.30 K $5.65 M   505.20% 0.26%
05/06/2025 127.21 K $4.75 M   -11.63% 0.22%
05/15/2025 126.30 K $4.72 M   100.00% 0.22%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 112.73 K $4.21 M   100.00% 0.19%
05/12/2025 110.86 K $4.14 M   100.00% 0.19%

Apogee Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 169 institutional investors and hedge funds held shares of Apogee Therapeutics, Inc.. The most heavily invested institutionals were:

Octagon Capital Advisors LP: 10.7 M

VR Adviser, LLC: 8.49 M

FMR LLC: 7.49 M

WELLINGTON MANAGEMENT GROUP LLP: 5.49 M

BlackRock, Inc.: 2.91 M

RTW INVESTMENTS, LP: 2.71 M

120.52% of Apogee Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 73.48 M shares in the last 24 months. This purchase volume represents approximately $2.82 B in transactions.